Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

SELL
$0.42 - $0.75 $22,350 - $39,912
-53,216 Reduced 18.39%
236,131 $113,000
Q4 2022

Feb 13, 2023

SELL
$0.66 - $1.02 $430 - $666
-653 Reduced 0.23%
289,347 $188,000
Q3 2022

Nov 14, 2022

SELL
$0.65 - $1.37 $49,801 - $104,966
-76,618 Reduced 20.9%
290,000 $281,000
Q2 2022

Aug 12, 2022

BUY
$0.39 - $0.84 $7,429 - $16,002
19,051 Added 5.48%
366,618 $274,000
Q1 2022

May 13, 2022

SELL
$0.51 - $1.0 $32 - $63
-63 Reduced 0.02%
347,567 $250,000
Q4 2021

Feb 11, 2022

SELL
$0.95 - $1.69 $4 - $8
-5 Reduced -0.0%
347,630 $345,000
Q3 2021

Nov 12, 2021

BUY
$1.53 - $2.22 $231,695 - $336,185
151,435 Added 77.18%
347,635 $531,000
Q2 2021

Aug 13, 2021

SELL
$2.27 - $3.44 $161,828 - $245,237
-71,290 Reduced 26.65%
196,200 $447,000
Q1 2021

May 12, 2021

BUY
$1.97 - $2.89 $191,596 - $281,072
97,257 Added 57.13%
267,490 $754,000
Q4 2020

Feb 12, 2021

BUY
$1.49 - $3.1 $1,445 - $3,007
970 Added 0.57%
170,233 $316,000
Q3 2020

Nov 13, 2020

BUY
$1.7 - $2.98 $870 - $1,525
512 Added 0.3%
169,263 $299,000
Q2 2020

Aug 13, 2020

BUY
$1.74 - $3.19 $110,162 - $201,965
63,312 Added 60.05%
168,751 $379,000
Q1 2020

May 14, 2020

SELL
$1.63 - $3.75 $12,156 - $27,967
-7,458 Reduced 6.61%
105,439 $201,000
Q2 2019

Aug 14, 2019

BUY
$1.29 - $1.83 $52,588 - $74,601
40,766 Added 56.52%
112,897 $161,000
Q1 2019

May 14, 2019

BUY
$1.67 - $3.12 $35,778 - $66,842
21,424 Added 42.25%
72,131 $123,000
Q3 2018

Nov 13, 2018

SELL
$0.7 - $1.58 $348 - $786
-498 Reduced 0.97%
50,707 $39,000
Q2 2018

Aug 14, 2018

BUY
$0.71 - $4.04 $5,334 - $30,356
7,514 Added 17.2%
51,205 $78,000
Q1 2018

May 15, 2018

BUY
$3.91 - $7.83 $6,811 - $13,639
1,742 Added 4.15%
43,691 $177,000
Q4 2017

Feb 13, 2018

BUY
$3.9 - $7.77 $4,789 - $9,541
1,228 Added 3.02%
41,949 $252,000
Q3 2017

Nov 14, 2017

BUY
$3.83 - $6.07 $7,066 - $11,199
1,845 Added 4.75%
40,721 $243,000
Q2 2017

Aug 14, 2017

BUY
N/A
38,876
38,876 $193,000

Others Institutions Holding VTVT

# of Institutions
1
Shares Held
243K
Call Options Held
0
Put Options Held
0

About vTv Therapeutics Inc.


  • Ticker VTVT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 81,483,600
  • Market Cap $1.43B
  • Description
  • vTv Therapeutics Inc., a clinical-stage biopharmaceutical company, focuses on the development of orally administered treatments for diabetes. The company is developing TTP399, an orally administered, small molecule, and liver-selective glucokinase activator for the treatment of type 1 diabetes; and HPP737, an orally administered non-CNS penetran...
More about VTVT
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.